RxDoctor Payments Data

Paul Newhouse

Psychiatry · Nashville, TNNPI 1962596734

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $4,245 of the $5,247 with a category attached, or 80.9%. Eisai Inc. accounts for 88.8% of it on its own, with 2 other manufacturers making up the rest.

$5,247in general payments, 2019–2025

Across 9 payments — averaging $583.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eisai Inc.$5K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$535
  • Axsome Therapeutics, Inc.$52
$1,406,157in research payments, 2019–2025

Across 180 payments — averaging $7811.98 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eisai Inc.$890K
  • Novartis$373K
  • Novo Nordisk AS$143K

What the payments were for

  • Consulting fees$4,24581%
  • Travel & lodging$74714%
  • Food & beverage$2555%

General payments by program year

22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,247 in reported general payments places this provider in the 85th percentile of 503 psychiatry providers in Tennessee.

See all psychiatry providers in Tennessee

Other psychiatry in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →